Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment

Notal Vision Ltd.50 enrolled

Overview

The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.

This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Age-Related Macular Degeneration

Interventions

FORESEE HOMEDEVICE

Home Monitoring

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who successfully completed participation in ForeseeHome-US2 study * Patients with ability to comprehend and sign the informed consent/authorization Exclusion Criteria: * Subjects who failed to complete participation in ForeseeHome-US2 study

Locations (1)

Vitreos retina center

Toms River, New Jersey, United States

Outcomes

Primary Outcomes

Subject compliance with Foresee HomeTM device

Time frame: 6 months

Secondary Outcomes

Assessment of the Telemedicine infrastructure

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.